FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

20,280 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 400 - 600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1032.18High Intensity Statin Therapy/Brandedactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.233All Results of High Risk HPV Testactive2023-09ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.234High Risk HPV Positive Resultsactive2023-09ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.263High Risk Positive HPV Results Without HPV16 or HPV18active2023-09ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.268HPV Negative Resultsactive2023-09ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.27Non pharmacologic treatments for chronic pain ICD10PCSactive2024-06uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1032.29Non pharmacologic treatments for chronic pain SCTactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.298Cervical Cytology Testactive2023-08usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.299HPV 16 Testsactive2023-09usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.300HPV 18 Testsactive2023-09usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.305Counseling for Physical Activity CPTactive2024-01uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1032.306Counseling for Physical Activity ICD10CMactive2024-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.307Counseling for Physical Activity CDSactive2024-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.322Test 123active2025-01usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.34Opioid pain medicationsactive2023-03usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.36Non pharmacologic treatments for chronic painactive2023-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.40Suicide attemptactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.42Naloxone and Nalmefene medicationsactive2024-01usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.43Benzodiazepine medicationsactive2024-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.44Stool softeners and laxativesactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.47Anxietyactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.48Anxietyactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.50Sleep disordered breathingactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.51Sleep disordered breathingactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.52Anxietyactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.53Sleep disordered breathingactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.54Adjuvant pain medicationsactive2023-03usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.6Non essential Hypertension ICD9CMactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.7Non essential Hypertension ICD10CMactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.79Behavioral Counseling for Nutrition and Activity Referralactive2023-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.85Impaired Glucose Toleranceactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.87Fasting Plasma Glucoseactive2023-05usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.88Waist Circumferenceactive2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1032.9Hypertensionactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.92First Degree Family Memberactive2024-06ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.94Glucose Tolerance Test Resultsactive2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1034.555Patient Declines Treatment for Cluster Headache (SNOMEDCT)active2025-05ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.558Acute Cluster Headache Medication (RXNORM)active2025-05usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.559Long Term Preventive Medication for Cluster Headacheactive2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.569Migraine Preventive Medicationactive2023-07usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.601Acute Migraine Attack Medicationactive2025-05usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.605NSAID OTC Migraine Attack Medicationactive2023-07usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.606NSAID Prescribable Migraine Attack Medicationactive2025-05usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.641Neuromodulation for migraineactive2023-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.642No pain with headacheactive2023-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.643Antiplateletsactive2023-07usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.644Anticoagulantsactive2023-07usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.645Statin Medicationsactive2023-07usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.646Anxiety Disorders (ICD10 and SNOMED)active2023-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.648Depression Diagnosis (ICD10 and SNOMED)active2023-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.649Psychosis (ICD10 and SNOMED)active2023-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.650Cluster Headache (SNOMED)active2023-12ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.651Galcanezumab (RxNorm)active2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.652Lithium (RxNorm)active2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.653Verapamilactive2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.654Long term preventive medications for cluster headacheactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.655Short term preventive medication for cluster headacheactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.656Zolmitriptanactive2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.657Sumatriptanactive2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.658Dihydroergotamineactive2023-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1034.659Acute cluster headache medicationactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.660Acute cluster headache treatmentactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.661Short term preventive treatment for cluster headacheactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.662Long term preventive treatment for cluster headacheactive2023-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.663Migraine diagnosis (ICD)active2025-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1034.664Prescribable NSAIDs and Acute Migraine Attack Medicationactive2025-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.103Abnormal Presentationactive2023-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1045.105Abnormal Presentationactive2021-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.130Respiratory Rateactive2023-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1045.15Intravenous Thrombolytic tPA Therapyactive2021-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1045.16Intraarterial Thrombolytic tPA Therapyactive2021-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1045.163Systolic Blood Pressureactive2023-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1045.171Abnormal Presentationactive2024-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1045.173Delivery of Singletonactive2021-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1045.21Intravenous or Intraarterial Thrombolytic tPA Therapyactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.26Estimated Gestational Age at Deliveryactive2021-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1045.27Cornual Ectopic Pregnancyactive2021-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1045.38General Or Neuraxial Anesthesiaactive2021-02uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1045.39Low Dose Unfractionated Heparin for VTE Prophylaxisactive2024-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1045.41Glycoprotein IIb IIIa Inhibitorsactive2023-01usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1045.55Oxytocinactive2021-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1045.56Dinoprostoneactive2025-05usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1045.58Delivery Proceduresactive2021-06uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1045.59Delivery Proceduresactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.67PCIactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.68Endotracheal Intubationactive2018-03uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1045.69Endotracheal Intubationactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1045.98Delivery of Singletonactive2021-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1045.99Delivery of Singletonactive2021-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1046.225Opioid Medication Assisted Treatment (MAT) SNOMEDactive2024-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1046.241Schedule II, III and IV Opioid Medicationsactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1046.242Opioid Use Disorderactive2024-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1046.243Opioid Use Disorderactive2024-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1046.265Inpatient, Emergency, and Observation Locationsactive2022-07uscdc
us.nlm.vsacR42.16.840.1.113762.1.4.1046.269Medications for Opioid Use Disorder (MOUD)active2024-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1046.274NHSN Inpatient Encounter Class Codesactive2024-04ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1046.277Emergency Department Locationactive2024-04uscdc
us.nlm.vsacR42.16.840.1.113762.1.4.1046.278Emergency Department Treatment Locationactive2025-02uscdc
us.nlm.vsacR42.16.840.1.113762.1.4.1046.283Emergency Department Locationactive2024-04ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1046.284Emergency Department Locationactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1046.285Mental Health Diagnosis without Substance Use Disordersactive2024-09usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1046.286Decision to Transferactive2024-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1046.35Healthcare Agent or Proxy Choicesactive2022-10usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1047.10Breastfeedingactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.100Familial Hypercholesterolemiaactive2021-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.102Rhabdomyolysisactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.107Low Intensity Statin Therapyactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.12Liver Diseaseactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.13Rhabdomyolysisactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.19Atherosclerosis and Peripheral Arterial Diseaseactive2025-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.20Atherosclerosis and Peripheral Arterial Diseaseactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.21Atherosclerosis and Peripheral Arterial Diseaseactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.22Liver Disease ICD9active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.37Stable and Unstable Anginaactive2025-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.39Cerebrovascular Disease Stroke or TIAactive2023-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.41Ischemic Heart Disease or Related Diagnosesactive2025-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.42Liver Diseaseactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.43Liver Diseaseactive2021-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.44Cerebrovascular Disease Stroke or TIAactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.46Ischemic Heart Disease or Related Diagnosesactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.47Stable and Unstable Anginaactive2024-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.501Overweight or Obeseactive2025-01usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.502Overweight or Obeseactive2018-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.512Elevated Blood Pressure Readingactive2019-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.513Elevated Blood Pressure Readingactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.514Finding of Elevated Blood Pressure or Hypertensionactive2019-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.515Bariatric Proceduresactive2024-02uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.517Age related macular degeneration intermediate dryactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.518Ophthalmologist visitactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.519Posterior vitreous detachment (PVD)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.521Ophthalmoscopic examactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.523Opthalmoscopic exams with Scleral Depressionactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.525Referral (ophthalmology)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.526Retina Ultrasoundactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.527Retina visualization inadequateactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.528Refusal or Noncompliance with treatmentactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.529Vitreous hemorrhageactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.530Vitreous hemorrhageactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.536Macula examinationactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.539Fluorescein angiographyactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.541Optical coherence tomography (OCT)active2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.542Intravitreal injectionactive2024-06uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.543Bevacizumab injectionactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.544Ranibizumab injectionactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.545Aflibercept injectionactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.552Uveitisactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.553Uveitisactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.554Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edemaactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.555Macular edemaactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.556Corticosteroids for Injectionactive2024-06uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1047.557Corticosteroids for Injectionactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.560Tonometryactive2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.561Intraocular pressureactive2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1047.571Retinal Vein Occlusion Related Macular Edemaactive2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.576Vitreous hemorrhageactive2020-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.580Intravitreal and Periocular Injectionsactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.581Intravitreal and Periocular Injectionsactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.582Corticosteroids for Injectionactive2020-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.583Endophthalmitis in the Right Eyeactive2020-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.584Endophthalmitis in the Left Eyeactive2020-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.585Panophthalmitis in the Right Eyeactive2020-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.586Panophthalmitis in the Left Eyeactive2020-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.587Lost to follow upactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.588Uveitisactive2020-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.610Scleral depressed examactive2020-03uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.6113 Mirror Goldmann examactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.612Scleral depressed examactive2022-03usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.615Physical Disabilityactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.616Financial difficultyactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.617Vitreous exam findingsactive2020-03usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1047.619Scleral depressed examactive2020-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.629Post operative follow upactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1047.67Breastfeedingactive2017-05usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.69Stable and Unstable Anginaactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.70Ischemic Heart Disease or Related Diagnosesactive2021-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.71Cerebrovascular Disease Stroke or TIAactive2023-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.73Breastfeedingactive2021-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1047.85Familial Hypercholesterolemiaactive2023-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.89Rhabdomyolysisactive2017-05usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.9Outpatient Encounters for Preventive Careactive2019-03ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1047.91Familial Hypercholesterolemiaactive2021-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.93Hypercholesterolemia ICD 9active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1047.97High Intensity Statin Therapyactive2024-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1047.98Moderate Intensity Statin Therapyactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1056.50HIV Lab Testsactive2025-02usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1056.51Indicators of Human Immunodeficiency Virus (HIV)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1056.52Indicators of Human Immunodeficiency Virus (HIV)active2024-06usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1056.53Indicators of Human Immunodeficiency Virus (HIV)active2024-06ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1056.71Human Immunodeficiency Virus (HIV) Viral Loadactive2024-06usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.10ARBs (Angiotensin Receptor Blockers)active2024-12usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1000OIA_V2_GLP1s_RxNormsactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1001OIA_V2_PCSK9s_RxNormsactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1002OIA_RFs_Secondary_Prevention_ICD10active2025-02usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1003OIA_RFs_Secondary_Prevention_SNOMEDactive2025-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1004OIA_RFs_Secondary_Prevention_CPTactive2025-02uscpt
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1005OIA_RFs_Secondary_Prevention_ICD_SM_CPTactive2025-02usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1006OIA_Asthma_COPD_Combo_Medsactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1007OIA_Asthma_COPD_Combo_Meds_SABA_SAMAactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1008OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICSactive2025-02usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.1009PAE_Patient_Conditionsactive2025-02ussct